Vanda Pharmaceuticals
VNDA
£3.50
Share price
-0.43%
Change (1 day)
-25.02%
Change (1 year)
Categories
Vanda Pharmaceuticals (VNDA) - Cash on Hand
Cash on Hand as of March 2025 : £0.25 Billion
According to Vanda Pharmaceuticals's latest financial reports the company has £0.25 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Vanda Pharmaceuticals - Cash on Hand chart (from 2005 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | £0.29 B | -2.04% |
| 2023-12-31 | £0.30 B | -21.03% |
| 2022-12-31 | £0.38 B | 20.35% |
| 2021-12-31 | £0.32 B | 18.85% |
| 2020-12-31 | £0.26 B | 13.34% |
| 2019-12-31 | £0.23 B | 17.4% |
| 2018-12-31 | £0.20 B | 91.07% |
| 2017-12-31 | £0.10 B | -7.36% |
| 2016-12-31 | £0.11 B | 18.56% |
| 2015-12-31 | £96.61 M | 15.87% |
| 2014-12-31 | £83.38 M | 5.52% |
| 2013-12-31 | £79.02 M | 6.08% |
| 2012-12-31 | £74.49 M | -22.23% |
| 2011-12-31 | £95.78 M | -25.33% |
| 2010-12-31 | £0.12 B | 1.12% |
| 2009-12-31 | £0.12 B | 300.22% |
| 2008-12-31 | £31.69 M | -26.06% |
| 2007-12-31 | £42.87 M | 163.5% |
| 2006-12-31 | £16.27 M | -9.94% |
| 2005-12-31 | £18.06 M | 113.31% |
| 2004-12-31 | £8.46 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | £5.38 B | 2,010.83% | 🇨🇭 Switzerland |
 Eli Lilly LLY | £2.41 B | 844.74% | 🇺🇸 USA |
 Johnson & Johnson JNJ | £29.03 B | 11,275.80% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | £8.82 B | 3,356.06% | 🇺🇸 USA |
 Pfizer PFE | £12.96 B | 4,979.38% | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | £1.45 M | -99.43% | 🇺🇸 USA |
 Merck MRK | £6.91 B | 2,606.89% | 🇺🇸 USA |